Additional value of (18)F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer

BACKGROUND: (18)F-FDG PET/CT can monitor metabolic activity in early breast cancer during neoadjuvant systemic therapy (NST), but it is unknown if the metabolic breast and axillary response differ. We evaluated the correlation between metabolic breast and axillary response at various time points dur...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ramshorst, Mette S., Teixeira, Suzana C., Koolen, Bas B., Pengel, Kenneth E., Gilhuijs, Kenneth G., Wesseling, Jelle, Rodenhuis, Sjoerd, Valdés Olmos, Renato A., Rutgers, Emiel J., Vogel, Wouter V., Sonke, Gabe S., Vrancken Peeters, Marie-Jeanne T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445462/
https://www.ncbi.nlm.nih.gov/pubmed/28545563
http://dx.doi.org/10.1186/s40644-017-0117-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445462/
https://www.ncbi.nlm.nih.gov/pubmed/28545563
http://dx.doi.org/10.1186/s40644-017-0117-5

Ejemplares similares